Resumo. BACKGROUND: The gait of individuals with Parkinson’s disease (PD) tends to be slower, characterized by narrow and short steps. During the medication, the self-selected gait speed of individuals with PD increases. However, when looking individually at the spatiotemporal parameters of gait, the medication induces different and not always consistent effects. However, the effects of medication and freezing of gait during walking in individuals with PD are unknown. AIM: To analyze the effect of antiparkinsonian medication and freezing of gait (FoG) on spatiotemporal gait parameters in individuals with PD. METHOD: For this purpose, we compared gait parameters in individuals with FoG (freezers, n=11) and without FoG (non-freezers, n=11). Spatiotemporal gait parameters (speed, cadence, step length, step time, step width, stride length, stride time, swing phase, and double support) and clinical scales (parts II and III of the Unified Parkinson’s Disease Rating Scale, Hoehn and Yahr, Montreal Cognitive Assessment questionnaire and Mini-Test scale of Balance Assessment System) were analyzed in two experimental sessions, counterbalanced between individuals: one in the ON medication state (1h after ingestion), and another in the OFF medication state (~12h after the last ingestion). Linear mixed effects models 2-groups X 2-conditions were used. RESULTS: We found that gait speed, stride, and step length were significantly higher in the ON than in the OFF condition for both freezers and non-freezers, and significantly lower in the freezers than in the non-freezers, regardless of the medication state. CONCLUSION: These results indicate that medication improved gait performance equivalently in both freezers and non-freezers.